Incidence of Acute GVHD
| Severity Grades . | GVHD Prophylaxis . | P Value* . | |
|---|---|---|---|
| . | (no. of patients [%]) . | . | |
| . | CSP . | CSP Plus MP . | . |
| . | (n = 59) . | (n = 61) . | . |
| A. Overall Grading | |||
| I-IV | 49 (83) | 41 (67) | 0.001 |
| II-IV | 44 (74) | 37 (60) | 0.01 |
| III-IV | 24 (40) | 21 (34) | 0.28 |
| B. Grading by Target Organ | |||
| Skin | |||
| I-IV | 43 (75) | 32 (56) | 0.03 |
| II-IV | 42 (74) | 28 (49) | 0.007 |
| III-IV | 35 (61) | 20 (35) | 0.005 |
| Liver | |||
| I-IV | 23 (40) | 17 (30) | 0.24 |
| II-IV | 18 (32) | 15 (26) | 0.84 |
| III-IV | 9 (16) | 11 (19) | 0.62 |
| Gut | |||
| I-IV | 25 (44) | 22 (39) | 0.57 |
| II-IV | 11 (19) | 10 (18) | 0.81 |
| III-IV | 8 (14) | 4 (7) | 0.22 |
| Severity Grades . | GVHD Prophylaxis . | P Value* . | |
|---|---|---|---|
| . | (no. of patients [%]) . | . | |
| . | CSP . | CSP Plus MP . | . |
| . | (n = 59) . | (n = 61) . | . |
| A. Overall Grading | |||
| I-IV | 49 (83) | 41 (67) | 0.001 |
| II-IV | 44 (74) | 37 (60) | 0.01 |
| III-IV | 24 (40) | 21 (34) | 0.28 |
| B. Grading by Target Organ | |||
| Skin | |||
| I-IV | 43 (75) | 32 (56) | 0.03 |
| II-IV | 42 (74) | 28 (49) | 0.007 |
| III-IV | 35 (61) | 20 (35) | 0.005 |
| Liver | |||
| I-IV | 23 (40) | 17 (30) | 0.24 |
| II-IV | 18 (32) | 15 (26) | 0.84 |
| III-IV | 9 (16) | 11 (19) | 0.62 |
| Gut | |||
| I-IV | 25 (44) | 22 (39) | 0.57 |
| II-IV | 11 (19) | 10 (18) | 0.81 |
| III-IV | 8 (14) | 4 (7) | 0.22 |
Univariable analysis.
Log-rank test for overall grading; χ2 test for grading by organ.